Sign in
4/A

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-14-000003

Chief Scientific Officer sold 253,050 shares at $0.12 ($29,683)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
NIGALAYE ASHOK G Chief Scientific Officer 2013-11-15 Sale −253,050 $0.12 $29,683 21,885,148 I
Open-market sales · 253,050 sh · avg $0.12 · $29,683
Loading xslF345X03/primary_doc.xml…